Windlas Biotech Limited (NSE:WINDLAS)

Windlas Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	159.27	52.88	36.86	5.7	159.3
Short-Term Investments	-	256.39	217.68	1,106	151.82
Trading Asset Securities	-	1,734	1,065	648.24	231.43
Cash & Short-Term Investments	159.27	2,044	1,320	1,760	542.55
Cash Growth	-92.21%	54.86%	-25.03%	224.44%	33.42%
Accounts Receivable	1,669	1,363	1,169	1,108	794.13
Other Receivables	32.8	6.66	4.38	22.13	1.31
Receivables	1,701	1,369	1,173	1,130	795.44
Inventory	3,048	621.89	747.38	587.1	414.61
Prepaid Expenses	-	9.84	8.71	9.54	11.09
Other Current Assets	343.06	268.08	286.61	329.76	179.42
Total Current Assets	5,251	4,313	3,535	3,817	1,943
Property, Plant & Equipment	2,219	1,803	1,227	983.15	954.95
Long-Term Investments	-	16.38	52.44	25.61	-
Other Intangible Assets	67.79	44.68	14.84	8.82	4.82
Long-Term Deferred Tax Assets	2.83	5.72	20.25	20.35	-
Other Long-Term Assets	63.32	79.54	439.85	55.67	58.35
Total Assets	7,605	6,262	5,290	4,910	2,961
Accounts Payable	1,672	1,315	877.43	632.32	399.33
Accrued Expenses	15.58	336.36	282.13	228.55	206.6
Short-Term Debt	-	-	-	53.13	294.05
Current Portion of Long-Term Debt	271.17	1.09	3.35	3.64	10.79
Current Portion of Leases	32.29	15.14	15.32	5.16	5.16
Current Income Taxes Payable	-	-	5.91	-	-
Other Current Liabilities	503.02	49.81	28.28	17.06	18.26
Total Current Liabilities	2,494	1,718	1,212	939.86	934.19
Long-Term Debt	-	-	1.09	4.44	8.32
Long-Term Leases	22.51	20.18	30.17	-	5.17
Long-Term Deferred Tax Liabilities	-	-	-	-	6.83
Other Long-Term Liabilities	29.84	25.01	23.36	18.03	15.53
Total Liabilities	2,547	1,763	1,267	962.33	970.04
Common Stock	104.8	103.99	104.63	108.97	64.11
Additional Paid-In Capital	-	1,946	1,986	2,269	754.91
Retained Earnings	-	2,396	1,900	1,551	1,172
Comprehensive Income & Other	4,953	53.45	32.19	18.04	-0.03
Total Common Equity	5,058	4,499	4,023	3,948	1,991
Shareholders' Equity	5,058	4,499	4,023	3,948	1,991
Total Liabilities & Equity	7,605	6,262	5,290	4,910	2,961
Total Debt	325.97	36.41	49.93	66.37	323.49
Net Cash (Debt)	-166.7	2,007	1,270	1,694	219.06
Net Cash Growth	-	58.08%	-25.04%	673.25%	86.75%
Net Cash Per Share	-7.89	96.16	58.69	82.64	12.03
Filing Date Shares Outstanding	20.95	20.8	20.95	21.79	18.21
Total Common Shares Outstanding	20.95	20.8	20.95	21.79	18.21
Working Capital	2,757	2,595	2,323	2,877	1,009
Book Value Per Share	241.38	216.33	192.05	181.14	109.36
Tangible Book Value	4,990	4,455	4,008	3,939	1,986
Tangible Book Value Per Share	238.14	214.18	191.34	180.73	109.10
Land	-	313.59	313.59	215.71	215.71
Buildings	-	637.59	489.59	453.6	451.74
Machinery	-	1,639	1,005	890.46	825.48
Construction In Progress	-	57.08	138.01	75.81	0.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.